Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Services-Health Services

Standard Industrial Classification: SIC 8000

Industry Insider Sentiment Analysis

The Services-Health Services sector (SIC 8000) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2022-06-23 23:09 2022-06-21 PRVA Privia Health Group, Inc. Bartrum Thomas Officer OPT+S $29.24 10,000 $292,360 91,355
2022-06-23 23:08 2022-06-21 PRVA Privia Health Group, Inc. Mehrotra Parth Officer OPT+S $29.22 60,000 $1,753,140 97,391
2022-06-23 01:24 2022-06-09 LFST LifeStance Health Group, Inc. Gouk Warren Officer SELL $7.32 10,000 $73,200 6,265,330
2022-06-17 23:30 2022-06-09 LFST LifeStance Health Group, Inc. Gouk Warren Officer SELL $7.32 5,000 $36,600 6,270,330
2022-06-17 02:11 2022-06-14 BTTX Better Therapeutics Inc. Armanino Andrew J. Director BUY $1.39 15,000 $20,846 15,000
2022-06-14 23:44 2022-06-13 LFST LifeStance Health Group, Inc. Patel-Dunn Anisha Officer SELL $5.34 3,463 $18,492 94,669
2022-06-14 23:44 2022-06-13 LFST LifeStance Health Group, Inc. Pardo Ryan Officer SELL $5.35 56,370 $301,580 500,688
2022-06-14 23:43 2022-06-13 LFST LifeStance Health Group, Inc. Qureshi Danish J. Officer SELL $5.32 85,879 $456,876 4,344,065
2022-06-14 23:43 2022-06-13 LFST LifeStance Health Group, Inc. Mullins Kevin Michael Officer SELL $5.30 78,858 $417,947 5,667,060
2022-06-14 23:42 2022-06-13 LFST LifeStance Health Group, Inc. Booth Gwen H. Officer SELL $5.27 88,798 $467,965 7,083,637
2022-06-14 23:41 2022-06-13 LFST LifeStance Health Group, Inc. Gorcyca Felicia Officer SELL $5.33 2,638 $14,061 909,582
2022-06-14 23:40 2022-06-13 LFST LifeStance Health Group, Inc. Lester Michael K. Director, Officer SELL $5.33 328,615 $1,751,518 23,148,931
2022-06-14 23:40 2022-06-09 LFST LifeStance Health Group, Inc. Gouk Warren Officer SELL $5.58 77,479 $432,186 6,265,330
2022-06-14 23:25 2022-06-13 BTTX Better Therapeutics Inc. Parker Geoffrey M. Director BUY $1.45 25,000 $36,183 40,000
2022-06-15 00:30 2022-06-10 PNTG Pennant Group, Inc. Christensen Christopher R. Director SELL $16.20 2,818 $45,652 152,405
2022-06-11 01:23 2022-06-10 BTTX Better Therapeutics Inc. Heinen Mark Officer BUY $1.56 5,000 $7,800 20,000
2022-06-10 23:39 2022-06-09 BTTX Better Therapeutics Inc. Armanino Andrew J. Director BUY $1.65 25,000 $41,355 151,328
2022-06-08 21:57 2022-06-06 PRVA Privia Health Group, Inc. Bartrum Thomas Officer OPT+S $25.01 10,000 $250,100 91,355
2022-06-08 21:55 2022-06-06 PRVA Privia Health Group, Inc. Mehrotra Parth Officer OPT+S $25.01 40,000 $1,000,400 97,391
2022-06-07 00:13 2022-06-03 BLDE Strata Critical Medical, Inc. LERER KENNETH B Director SELL $7.05 66,869 $471,520 145,179
2022-06-03 01:59 2022-05-31 BLDE Strata Critical Medical, Inc. LERER KENNETH B Director SELL $7.29 281,303 $2,050,389 168,488
2022-05-28 01:45 2022-05-25 BLDE Strata Critical Medical, Inc. LERER KENNETH B Director SELL $7.04 470,693 $3,311,937 266,544
2022-05-25 03:35 2022-05-20 SMFR GeneDx Holdings Corp. Schadt Eric Director, Officer BUY $1.92 100,000 $192,480 243,380
2022-05-13 03:27 2022-05-11 SMFR GeneDx Holdings Corp. Assad Shawn Officer OPT+S $1.75 3,128 $5,475 32,107
2022-05-13 03:22 2022-05-10 SMFR GeneDx Holdings Corp. Ro Isaac Officer OPT+S $2.46 19,515 $48,007 201,786
2022-05-06 02:27 2022-04-29 SMFR GeneDx Holdings Corp. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 10% owner BUY $4.00 6,250,000 $25,000,000 94,605,473
2022-05-03 23:01 2022-04-29 SMFR GeneDx Holdings Corp. Casdin Eli Director BUY $4.00 11,437,500 $45,750,000 16,437,500
2022-05-04 03:26 2022-04-29 SMFR GeneDx Holdings Corp. BTO Sema4 Holdings L.P. 10% owner BUY $4.00 2,500,000 $10,000,000 162,309
2022-05-03 23:01 2022-04-29 SMFR GeneDx Holdings Corp. Meister Keith A. Director BUY $4.00 11,437,500 $45,750,000 26,931,250
2022-05-04 03:28 2022-04-29 SMFR GeneDx Holdings Corp. Blackstone Tactical Opportunities Associates III - NQ L.P. 10% owner BUY $4.00 2,500,000 $10,000,000 162,309
2022-05-03 01:54 2022-04-28 SMFR GeneDx Holdings Corp. Prentice Anthony Officer SELL $2.18 1,691 $3,688 9,860
2022-05-03 01:50 2022-04-28 SMFR GeneDx Holdings Corp. White Karen Ann Officer SELL $2.18 1,430 $3,118 9,506
2022-05-03 01:48 2022-04-28 SMFR GeneDx Holdings Corp. Schadt Eric Director, Officer SELL $2.18 35,899 $78,274 143,380
2022-05-03 01:47 2022-04-28 SMFR GeneDx Holdings Corp. Clark Daniel Emmett Officer SELL $2.18 1,212 $2,643 309,547
2022-04-23 01:00 2022-04-20 LFST LifeStance Health Group, Inc. Mullins Kevin Michael Officer SELL $10.68 46,283 $494,302 5,669,472
2022-04-22 19:31 2022-04-20 PRVA Privia Health Group, Inc. Mehrotra Parth Officer OPT+S $27.93 20,000 $558,600 97,391
2022-04-22 16:18 2022-04-20 PRVA Privia Health Group, Inc. Bartrum Thomas Officer OPT+S $27.93 10,000 $279,300 27,391
2022-04-21 23:21 2022-04-20 SMFR GeneDx Holdings Corp. Saad Kareem Officer OPT+S $2.49 6,269 $15,610 64,289
2022-04-21 02:06 2022-04-19 PNTG Pennant Group, Inc. Stringfield JoAnne Director SELL $16.50 190 $3,135 7,395
2022-04-21 02:07 2022-04-18 PNTG Pennant Group, Inc. Christensen Christopher R. Director BUY $16.50 2,668 $44,022 581,133
2022-04-16 01:56 2022-04-13 PNTG Pennant Group, Inc. Christensen Christopher R. Director BUY $16.50 27,332 $450,959 578,465
2022-04-09 00:08 2022-04-06 SMFR GeneDx Holdings Corp. Ro Isaac Officer SELL $2.91 1,284 $3,737 158,801
2022-04-04 23:28 2022-03-31 BTTX Better Therapeutics Inc. Heinen Mark Officer BUY $1.98 5,000 $9,900 15,000
2022-04-04 23:27 2022-03-31 BTTX Better Therapeutics Inc. Appelbaum Kevin J Director, Officer, 10% owner BUY $1.97 2,500 $4,921 6,250
2022-03-31 23:39 2022-03-29 BTTX Better Therapeutics Inc. Armanino Andrew J. Director BUY $2.14 40,000 $85,620 126,328
2022-03-31 23:38 2022-03-29 BTTX Better Therapeutics Inc. Parker Geoffrey M. Director BUY $2.15 15,000 $32,231 15,000
2022-03-31 03:34 2022-03-28 PRVA Privia Health Group, Inc. Bartrum Thomas Officer OPT+S $25.09 10,000 $250,900 27,391
2022-03-31 03:33 2022-03-28 PRVA Privia Health Group, Inc. Mehrotra Parth Officer OPT+S $25.09 20,000 $501,800 97,391
2022-03-18 21:04 2022-03-17 USPH U S PHYSICAL THERAPY INC /NV Chapman Harry S Director SELL $96.02 1,280 $122,906 30,900
2022-03-17 17:00 2022-03-15 USPH U S PHYSICAL THERAPY INC /NV Chapman Harry S Director SELL $94.75 3,320 $314,586 32,180
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Services-Health Services sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8000) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Services-Health Services

Every transaction in the Services-Health Services industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.